EUVIMEDEUVIMED entdecken
Crossref

Association between obstructive sleep apnea and liver fibrosis in patients with suspected nonalcoholic fatty liver disease

Wojciech Trzepizur iD, Jérôme Boursier, Jérémie Poilane, Christophe Bureau, Kamila Sedkaoui, Sandrine Pontier, Charlotte Costentin, Jean-Louis Pépin iD, Matthieu Schnee, Acya Bizieux, Maeva Guillaume, Jean-François Hamel und 1 weitere

SLEEPJ · 2026

DOI: 10.1093/sleep/zsaf265 ↗

Kurz gefasst

Fachartikel in der Zeitschrift SLEEPJ, 2026. Verfasst von Wojciech Trzepizur und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Respiratory and Sleep Medicine, Angers University Hospital, Angers, France. Hauptthemen laut MEDLINE: Sleep Apnea, Obstructive, Non-alcoholic Fatty Liver Disease, Liver Cirrhosis. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 32 Literaturangaben. Gefördert von: Christelle Gosselin and Jean-Louis Racineux, Institut de Recherche en Santé Respiratoire des Pays de la Loire.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Study Objectives The association between obstructive sleep apnea (OSA) and liver fibrosis has been primarily evaluated using noninvasive tools or in selected populations (bariatric surgery). The aim of the study was to determine whether OSA is associated with liver fibrosis in patients with suspected nonalcoholic fatty liver disease (NAFLD) referred for liver biopsy (LB).

Methods

Patients who underwent percutaneous LB for suspected NAFLD were prospectively included and investigated by in-lab polysomnography. Liver lesions were evaluated using the NASH-CRN scoring system and advanced fibrosis was defined as F ≥ 3. Moderate to severe OSA was defined by an apnea–hypopnea index (AHI) ≥15 events/h.

Results

Among the 97 patients included in the study, 40 exhibited advanced fibrosis, while 63 demonstrated moderate to severe OSA. The prevalence of moderate to severe OSA in patients with advanced fibrosis was 82% versus 52% in patients with F0–2 fibrosis stage (p < .0037). The association between moderate to severe OSA and advanced fibrosis remained significant after adjustment for sex, age, diabetes and obesity with an OR of 3.48 (CI = 1.03% to 11.83%; p = .045). Similar association was found with nocturnal hypoxia markers (oxygen desaturation index and the time spent under 90% of saturation). No association was observed between moderate to severe OSA and steatosis or nonalcoholic steatohepatitis.

Conclusions

Utilizing the gold-standard tools for OSA and NAFLD diagnosis in a multicentric cohort of biopsy-proven NAFLD patients, an independent association between OSA and liver fibrosis was confirmed. Statement of Significance This study provides the strongest evidence to date that obstructive sleep apnea (OSA) is independently associated with advanced liver fibrosis in patients with biopsy-proven NAFLD. Unlike prior studies based on indirect measures or bariatric populations, this work used gold-standard diagnostics—full polysomnography and liver histology—in a general NAFLD cohort. The high prevalence of OSA among patients with advanced fibrosis suggests systematic screening may be warranted. These findings identify OSA as a potential modifiable risk factor for liver disease progression.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Sleep Apnea, ObstructiveNon-alcoholic Fatty Liver DiseaseLiver CirrhosisHumansMaleFemaleMiddle AgedPolysomnographyProspective StudiesAdultPrevalenceBiopsySeverity of Illness IndexRisk Factors

Stichwörter der Autor:innen

liver fibrosisnonalcoholic fatty liver disease, NASHobstructive sleep apnea

Autor:innen und Institutionen

  • Department of Respiratory and Sleep Medicine, Angers University Hospital, Angers, France.
  • INSERM, CNRS, MITOVASC, University of Angers, Angers, France.
  • Department of Hepato-Gastroenterology, Angers University Hospital, Angers, France.
  • HIFIH Laboratory, SFR ICAT 4208, Angers University, Angers, France.
  • Department of Hepatology, Hôpital Rangueil, Fédération Hospitalo-Universitaire IMPACT, CHU de Toulouse, et Université Toulouse 3 - Paul Sabatier, Toulouse, France.
  • Departement of Respiratory Diseases, Hôpital Larrey, Centre Hospitalier Régional et Universitaire de Toulouse, Toulouse, France.

ORCID-Profile: Wojciech Trzepizur, Jean-Louis Pépin, Frédéric Gagnadoux

Förderung

  • Christelle Gosselin and Jean-Louis Racineux
  • Institut de Recherche en Santé Respiratoire des Pays de la Loire

Zitieren

APA

Trzepizur, W., Boursier, J., Poilane, J., Bureau, C., Sedkaoui, K., Pontier, S., Costentin, C., Pépin, J. L., Schnee, M., Bizieux, A., Guillaume, M., Hamel, J. F., & Gagnadoux, F. (2026). Association between obstructive sleep apnea and liver fibrosis in patients with suspected nonalcoholic fatty liver disease. SLEEPJ. https://doi.org/10.1093/sleep/zsaf265

Vancouver

Trzepizur W, Boursier J, Poilane J, Bureau C, Sedkaoui K, Pontier S, et al. Association between obstructive sleep apnea and liver fibrosis in patients with suspected nonalcoholic fatty liver disease. SLEEPJ. 2026. doi:10.1093/sleep/zsaf265

BibTeX
@article{Trzepizur2026,
  author = {Trzepizur, Wojciech and Boursier, Jérôme and Poilane, Jérémie and Bureau, Christophe and Sedkaoui, Kamila and Pontier, Sandrine and Costentin, Charlotte and Pépin, Jean-Louis and Schnee, Matthieu and Bizieux, Acya and Guillaume, Maeva and Hamel, Jean-François and Gagnadoux, Frédéric},
  title = {Association between obstructive sleep apnea and liver fibrosis in patients with suspected nonalcoholic fatty liver disease},
  journal = {SLEEPJ},
  year = {2026},
  doi = {10.1093/sleep/zsaf265}
}
Kostenlos starten →